MedAvail Holdings, Inc. MDVLQ

0.00 0.00 NaN as of 24 Sep

Market cap: $2.9M
P/E: 0.0×

Follow MDVLQ

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions

in millions of $

	Nov 25			Feb 26			May 26			Aug 26
Buy	—	—	—	—	—	—	—	—	—	—	—	—
Sell	—	—	—	—	—	—	—	—	—	—	—	—

Insider Ownership 34.93%

Capital & Financial Ratios

Market Cap 2.90

Revenue 43.33

Net Income (46.00)

Free Cash Flow (32.23)

Net Debt (13.32)

Current Ratio 6.51

Debt/Equity 0.07

P/E ratio 0.00

P/S ratio 0.00

P/B ratio 0.00

Past 5Y EPS Growth 38.58%

This Y EPS Growth —

Next Y EPS Growth —

Next 5Y EPS Growth —

in millions of $

Dividends

Payout Ratio 0.00

Annual Dividend Rate —

Annual Dividend Yield —

	total	individual payouts
2023	Powerpack
2022	Powerpack
2021	Powerpack
2020	Powerpack
2019	Powerpack
2018	Powerpack
2017	Powerpack

predictions in italic, special payouts not included in total or ratios

Assets vs Liabilities

	2020	2021	2022	Q'23
Cash	58	20	12	15
Receivables	2	1	2	0
Inventory	3	4	7	10
Other	2	2	3	2
	64	27	24	27

	2020	2021	2022	Q'23
Payables	1	4	2	1
ST’ Debt	3	1	1	0
Other	3	3	4	3
	8	8	6	4

in millions of $

Compound Annual Growth

	10y	5y	3y
Sales	55.37%	25.28%	24.89%
Cash Flow	0.00%	0.00%	0.00%
Earnings	0.00%	0.00%	0.00%
Book Value	16.91%	(19.36%)	2.97%

Revenue

	Mar	Jun	Sep	Dec	Year
’26	1	0	—	—	—
’22	0	1	11	31	43
’22	—	—	—	—	43
’21	4	5	6	7	22
’21	—	—	—	—	22
’20	1	2	7	3	14
’20	—	—	—	—	14

in millions of $ · fiscal quarters ending in the months shown

Operating Cash Flow

	Mar	Jun	Sep	Dec	Year
’26	(5)	(4)	—	—	—
’22	(13)	(12)	(12)	(10)	(48)
’22	—	—	—	—	(48)
’21	(10)	(7)	(12)	(14)	(43)
’21	—	—	—	—	(43)
’20	(6)	(4)	(5)	(13)	(29)
’20	—	—	—	—	(29)

in millions of $ · fiscal quarters ending in the months shown

Free Cash Flow

	Mar	Jun	Sep	Dec	Year
’26	(5)	(4)	—	—	—
’22	(14)	(13)	(12)	(11)	(50)
’22	—	—	—	—	(48)
’21	(11)	(7)	(12)	(15)	(46)
’21	—	—	—	—	(43)
’20	(6)	(4)	(5)	(14)	(29)
’20	—	—	—	—	(29)

in millions of $ · fiscal quarters ending in the months shown

EPS

	Mar	Jun	Sep	Dec	Year
’26	(11.00)	(3.22)	—	—	—
’22	(20.00)	(8.50)	(7.50)	(7.00)	(36.00)
’22	—	—	—	—	(36.20)
’21	(14.50)	(16.00)	(17.00)	(19.00)	(67.00)
’21	—	—	—	—	(67.09)
’20	(157.36)	(167.33)	(60.80)	(35.50)	(234.50)
’20	—	—	—	—	(234.27)

fiscal quarters ending in the months shown

2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
—	—	—	—	—	—	—	450.00	60.50	12.05	Analyst estimates 2023–2025 Powerpack	Low Price
—	—	—	—	—	—	—	1,039.50	874.00	178.00		High Price
—	—	—	9	10	12	15	224	287	279		Employees
—	—	—	0	0	0	0	0	0	0		Revenue/Emp
—	—	—	0	1	0	4	14	22	43		Revenue
—	—	—	2.45%	41.44%	31.11%	25.14%	36.96%	1.43%	6.00%		Gross Margin
—	—	—	(4)	(4)	(4)	(22)	(27)	(44)	(48)		EBT
—	—	—	(1,327.52%)	(771.48%)	(1,207.50%)	(571.02%)	(191.94%)	(197.99%)	(110.40%)		EBT Margin
—	—	—	(4)	(4)	(3)	(22)	(27)	(44)	(48)		Net Income
—	—	—	0	0	0	2	2	3	5		Depreciation
—	—	—	40.88	53.67	30.25	117.11	122.10	33.88	32.77		Revenue/Sh
—	—	—	(540.22)	(414.17)	(270.11)	(668.31)	(234.50)	(67.00)	(36.00)		Earnings/Sh
—	—	—	(459.12)	(386.02)	(273.11)	(607.02)	(250.30)	(65.10)	(36.23)		Cash Flow/Sh
—	—	—	(47.62)	(0.20)	0.00	(12.48)	(7.14)	(5.04)	(1.75)		Capex/Sh
—	—	—	(506.75)	(386.22)	(273.11)	(619.50)	(257.44)	(70.14)	(37.98)		Free CF/Sh
—	—	—	664.75	445.31	237.06	(3,001.40)	533.80	29.20	15.83		Book Value/Sh
—	—	—	0	0	0	0	0	1	1		Shares
—	—	—	0.00	0.00	0.00	0.00	0.00	0.00	0.00		PE Ratio
—	—	—	16.73	15.76	28.16	6.20	6.16	2.07	0.45		PS Ratio
—	—	—	1.03	1.90	3.59	0.00	1.41	2.40	0.92		PB Ratio
—	—	—	11.03	14.01	28.12	7.47	2.21	1.62	0.29		EV/Sales
—	—	—	(0.88)	(1.77)	(2.78)	(1.38)	(1.05)	(0.78)	(0.25)		EV/FCF
—	—	—	(4)	(4)	(3)	(20)	(29)	(43)	(48)		Op' Cash Flow
—	—	—	0	0	—	0	(1)	(3)	(2)		Capex
—	—	—	(4)	(4)	(3)	(20)	(29)	(46)	(50)		FCF
—	—	—	3	2	1	6	56	20	18		Working Cap'
—	—	—	—	—	1	13	2	10	5		Total Debt
—	—	—	(2)	(1)	0	4	(56)	(11)	(7)		Net Debt
—	—	—	5	4	3	(97)	61	19	21		Sh' Equity
—	—	—	(72.82%)	(84.63%)	(72.35%)	(119.61%)	(38.67%)	(114.87%)	(143.72%)		ROA
—	—	—	(77.98%)	(73.89%)	(96.42%)	0.00%	(304.64%)	(319.09%)	(214.88%)		ROIC
—	—	—	(81.63%)	(92.99%)	(114.25%)	22.28%	(43.90%)	(229.72%)	(228.66%)		ROE

predictions in italic, sparklines do not include predictions

All 10 years →

Fiscal years to Dec 2022 · latest quarter Jun 2023

Company	Market cap	P/E	Compare
RDGT Ridgetech Inc.	$3.3M	0.0×	Compare
POM Pomdoctor Limited - Sponsored ADR	$7.8M	—	Compare
MEDS DataMeds AI, Inc	$10.9M	0.0×	Compare
SCNX Scienture Holdings, Inc.	$12.3M	0.0×	Compare

Company	Market cap	P/E	Compare
PETS PetMed Express, Inc.	$33.7M	0.0×	Compare
BIMI BIMI Holdings Inc.	$170.0K	0.0×	Compare
HITI High Tide Inc.	$240.2M	0.0×	Compare

All 8 Pharmaceutical Retailers stocks →